These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3942829)

  • 1. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Peerschke EI; Francis CW; Marder VJ
    Blood; 1986 Feb; 67(2):385-90. PubMed ID: 3942829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS; Shattil SJ; Power JW; Gartner TK
    J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen interactions with platelets in plasma.
    Adelman B; Rizk A; Hanners E
    Blood; 1988 Nov; 72(5):1530-5. PubMed ID: 3179439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
    Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
    J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.
    Peerschke EI
    Blood; 1991 Feb; 77(3):508-14. PubMed ID: 1899346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin.
    Haidaris PJ; Peerschke EI; Marder VJ; Francis CW
    Blood; 1989 Nov; 74(7):2437-44. PubMed ID: 2478231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
    Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
    Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1984 Dec; 64(6):1163-8. PubMed ID: 6437459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen fragments and platelet dysfunction in uremia.
    Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
    Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine.
    Shattil SJ; Motulsky HJ; Insel PA; Flaherty L; Brass LF
    Blood; 1986 Dec; 68(6):1224-31. PubMed ID: 3779100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS
    J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
    Sloan SM; Brown EB; Liu Q; Frojmovic MM
    Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.